SUSTAINABILITY REPORT 2013-15

People Overview Self Managed Teams Mechanisation Safety Overview The Parivartan     Journey Progress on     Roadmap Incident Statistics Robust Governance Standardised     Processes Enhanced Awareness Capability Building Safety Infrastructure Safety Audits Quality Overview Top-down    Accountability Quality by Design Quality Culture     Transformation Quality Assurance Quality     Best Practices All Time Audit     Readiness Availability Overview Strategic Sourcing Risk Management Product    Rationalisation Success stories Environment Overview Roadmap Energy Management Emissions Water Waste Case Study KPIs Community Overview Focus Areas Education Livelihoods Healthcare Infrastructure     Initiatives Creating Change     Makers Productivity Overview Productivity Streams Case Study PACE Update Initiatives Engineering Excellence Overview Digitisation Automation Mechanisation Lean Manufacturing Capital Equipment Strategy Predictive Maintenance Continuous Improvement Overview Continuous     Improvement     at Work Best Practices Annexures GRI Index Acronyms Assurance Statement   Summary Report     OVERTAKE DEMAND AVAILABILITY Unfulfilled demand is a terminal disease that plagues the pharmaceutical sector. At Dr. Reddy's, as part of our operational strategy to ensure good health for all, we have set ourselves the aspirational goal to overtake demand in all markets. Thus, not only are we expanding our geographical footprint and penetrating deeper in the markets, we are also ensuring that markets where we are present are efficiently serviced and our medicines are on the shelves whenever the need arises.       Overview     Ill-health can strike anytime, anywhere and thus it is imperative that our medicines are available all the time, everywhere.   At Dr. Reddy’s, we constantly work with a singular purpose of accelerating access to affordable and innovative medicines to people around the world. Be it through increasing supply of our medicines to overtake demand, or identifying market as a constraint and restructuring our processes around it.   Simplification of product portfolio and reducing manufacturing complexities frees up capacities and resources to produce more, hence product rationalisation is one of the mechanism we use to augment production.   As we accelerate towards our purpose, we are also managing risks on the way. A business continuity plan, alternate vendor development and de-risking of top molecules are some of the frameworks we have put in place to manage supply chain risks.